Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Lynparza combination therapy gets FDA priority review for prostate cancer

August 17, 2022 Research and Development

Lynparza is being jointly developed by UK-based AstraZeneca and MSD AstraZeneca’s supplemental new drug application for Lynparza (olaparib) in combination …
News
surgery-1822458_960_720

Successful study to change the blood type of donor kidneys means access for more BAME recipients

August 17, 2022 Research and Development

Scientists at the University of Cambridge have successfully altered the blood type of donor kidneys in a study which could …
News
istockphoto-1266494637-170667a

Patient with HNSCC dosed with triple combination therapy in Phase II of Genexine clinical trial

August 17, 2022 Research and Development

Genexine, a South Korean clinical-staged biopharmaceutical company, have announced the dosing with triple combination therapy of the first patient with …
News
x-ray-6841384__480

Study highlights major factors in shaping cross-disorder cortical abnormalities

August 10, 2022 Research and Development

The study began by constructing maps of cortical abnormalities from thirteen neurodevelopmental, neurological, and psychiatric disorders. These maps came from …
News

Survey reveals 45% of junior doctors are considering leaving the profession

August 10, 2022 Research and Development

1 in 3 (36%) of GPs and 1 in 4 (25%) of specialists surveyed were also looking to pursue a …
News

Karuna Therapeutics announces positive results from Phase III trial into schizophrenia

August 10, 2022 Research and Development

Karuna Therapeutics has announced positive topline results from its Phase III EMERGENT-2 trial, evaluating the efficacy, safety, and tolerability of …
News

Tagrisso combined with Hutchmed drug clears lung cancer test

August 10, 2022 Research and Development

Tagrisso and Hutchmed have revealed positive Phase II data on their combination drug, which prompts the two partners to progress …
News

PCI Pharma Services announces multi-million dollar expansion to UK manufacturing facility

July 27, 2022 Research and Development

PCI has announced a significant expansion of its facility in Tredegar, Wales, UK, designed to help keep up to date …
News

Micronesia’s first COVID outbreak sees steep rise in cases

July 27, 2022 Research and Development

Micronesia’s first outbreak of COVID-19 has grown in one week to over 1,000 cases, causing significant alarm in the Pacific …
News

Updated NICE pre-eclampsia guidance

July 27, 2022 Research and Development

New NICE guidance has been released, recommending the routine use of placental growth factor (PIGF), based on testing in the …
News

Depression may not be caused by chemical imbalance

July 20, 2022 Research and Development

A major review has found “no clear evidence” that low serotonin levels are responsible for depression. Reviewing existing studies, researchers …
News

COVID-19 boosters to be offered to all over 50s this autumn

July 20, 2022 Research and Development

All those aged 50 and over will be offered a COVID-19 booster vaccine this autumn, to top up their immunity …
News

Potential shortage of 140,000 nurses in NHS England by 2030

July 20, 2022 Research and Development

According to new analysis, the NHS in England could face a shortfall of almost 40,000 nurses by 2024, and under …
News

TSB and CR Pharma partner for COVID-19 antibody therapy in China

July 20, 2022 Research and Development

TSB Therapeutics has entered a collaboration with China Resources Pharmaceutical Commercial Group (CR Pharma) for the commercialisation of an antibody …
News

Gene editing potential treatment for hereditary killer

July 13, 2022 Research and Development

Verve therapeutics has dosed the first patient win its heart-1 clinical trial, studying the safety and efficacy of its in …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025